Dr. Xieng Lee, DDS is Featured in an Exclusive Interview with Infinite Sights
Dr. Xieng Lee, DDS a renowned dentist and community advocate based at Quality Dental Care in Brooklyn Park, MN, was...
Year: 2024
BIO-Europe(R) Celebrates 30th Anniversary with Landmark Event in Stockholm
MUNICH, GERMANY / ACCESSWIRE / August 5, 2024 / Join the 30th anniversary edition of BIO-Europe®, the premier biopharma partnering...
Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer
REDWOOD CITY, CA / ACCESSWIRE / August 5, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the...
AFB Names 2024 Migel Medal Honorees
WASHINGTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- The American Foundation for the Blind (AFB) has announced that Kim Charlson and...
Safety Shot to Release On-the-Go Powder Stick Packs of the World’s First Alcohol Reducing Product
With an Expected Launch in Early Q4, Safety Shot Powder Stick Packets Will Address an Anticipated $517M Market Size JUPITER,...
Onco360® Has Been Selected as a National Specialty Pharmacy for crovalimab-akkz
LOUISVILLE, Ky., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Genentech,...
Excision BioTherapeutics Awarded a “Fierce 15” Biotech Company of 2024
Company Applying its Proprietary CRISPR Technology to Address Recurrent Infections in Herpes Simplex Keratitis (HSK)HSK is the Leading Cause of...
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company...
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team
TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC...
Edison Issues Report on Topps Tiles (TPT)
London, United Kingdom--(Newsfile Corp. - August 5, 2024) - Edison issues report on Topps Tiles (LSE: TPT).Topps Tiles is the...
Skanray Partners with Tata Elxsi to Advance Surgical Imaging and Healthcare Innovation
BENGALURU, India, Aug. 5, 2024 /PRNewswire/ -- Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging,...
CBD of Denver Announces Q2 Revenue and Provides Update on German Market
Denver, Colorado--(Newsfile Corp. - August 5, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that revenue for...
Relief Therapeutics Secures up to $11 Million from Royalty Sales
Non-dilutive funding to support RLF-TD011 clinical development and pipeline advancement GENEVA, SWITZERLAND / ACCESSWIRE / August 5, 2024 / RELIEF...
Matty Renos Announces New 17-Unit Real Estate Development in Dartmouth, Nova Scotia
Nova Scotia Company Expands Portfolio with Innovative ProjectDartmouth, Nova Scotia--(Newsfile Corp. - August 4, 2024) - Matty Renos, a leading...
NTG Nordic Transport Group acquires SCHMALZ+SCHÖN Holding GmbH
Company announcement no. 6 – 24 2 August 2024 NTG Nordic Transport Group acquires SCHMALZ+SCHÖN Holding GmbH NTG Germany GmbH...
FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C
PDUFA Action Date for the Arimoclomol NDA is September 21, 2024CELEBRATION, Fla., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics,...
Avicanna Announces Changes of Auditors
TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a...
Digicann Ventures and 3Win Corp. Sign Binding LOI for Proposed RTO Transaction
/Not for distribution to U.S. news wire services or for dissemination in the United States/ VANCOUVER, British Columbia, Aug. 02,...
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and...
Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine
LONG BEACH, Calif., Aug. 2, 2024 /PRNewswire/ -- Anivive Lifesciences Inc, a One Health technology company today announced that the National...